In vitro neuromuscular activity of 'colubrid' venoms: clinical and evolutionary implications.

Lumsden, Natalie G; Fry, Bryan G; Manjunatha Kini, R; Hodgson, Wayne C

Lumsden, Natalie G; Fry, Bryan G; Manjunatha Kini, R; Hodgson, Wayne C.

Affiliation

Lumsden NG; Monash Venom Group, Department of Pharmacology, Monash University, Melbourne, Vic. 3800, Australia.

Toxicon ; 43(7): 819-27, 2004 Jun 01.

Article in En | MEDLINE | ID: mdl-15284016

Subject(s)

Muscle Contraction/drug effects; Neuromuscular Agents/toxicity; Neuromuscular Junction/drug effects; Snake Venoms/toxicity; Snakes; Analysis of Variance; Animals; Chickens; Neostigmine/pharmacology; Neuromuscular Agents/antagonists & inhibitors; Neuromuscular Agents/metabolism; Phospholipases A/metabolism; Phospholipases A2; Phylogeny; Snake Venoms/antagonists & inhibitors; Snake Venoms/metabolism; Species Specificity; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Snake Venoms / Snakes / Muscle Contraction / Neuromuscular Agents / Neuromuscular Junction Limits: Animals Language: En Journal: Toxicon Year: 2004 Document type: Article Affiliation country: Australia

Search on Google

Add to My VHL

XML

PubMed Links